EP 3506931 B1 20240731 - METHODS FOR PREVENTING OR TREATING ALLERGY BY ADMINISTERING AN IL-4R ANTAGONIST
Title (en)
METHODS FOR PREVENTING OR TREATING ALLERGY BY ADMINISTERING AN IL-4R ANTAGONIST
Title (de)
METHODEN ZUR BEHANDLUNG VON ALLERGIEN MITTELS ANWENDUNG EINES IL-4R ANTAGONISTEN
Title (fr)
MÉTHODES DE PRÉVENTION OU DE TRAITEMENT DE L'ALLERGIE PAR ADMINISTRATION D'UN ANTAGONISTE D'IL-4 R
Publication
Application
Priority
- US 201662382501 P 20160901
- US 201662425726 P 20161123
- US 2017049538 W 20170831
Abstract (en)
[origin: WO2018045130A1] The present invention provides methods for preventing or treating allergy. Also provided are methods for reducing the susceptibility to an allergen in a subject in need thereof. In certain embodiments, the subject has a disease or disorder selected from the group consisting of atopic dermatitis, asthma, allergic rhinitis, and eosinophilic esophagitis. The methods of the present invention comprise administering to a subject in need thereof a pharmaceutical composition comprising an interleukin-4 receptor (IL-4R) antagonist such as an anti-IL-4R antibody.
IPC 8 full level
A61K 39/00 (2006.01); A61P 37/08 (2006.01); C07K 16/28 (2006.01)
CPC (source: CN EP KR US)
A61K 9/0019 (2013.01 - CN US); A61K 38/1774 (2013.01 - EP US); A61K 39/00 (2013.01 - EP US); A61K 39/3955 (2013.01 - CN); A61K 45/06 (2013.01 - CN KR); A61P 17/00 (2018.01 - EP US); A61P 37/08 (2018.01 - CN EP KR US); C07K 16/2866 (2013.01 - CN EP KR US); G01N 33/56966 (2013.01 - US); A61K 45/06 (2013.01 - US); A61K 2039/505 (2013.01 - CN EP KR US); A61K 2039/54 (2013.01 - CN); A61K 2039/545 (2013.01 - CN EP KR US); C07K 2317/565 (2013.01 - CN); C07K 2317/76 (2013.01 - CN EP KR US)
C-Set (source: CN)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated validation state (EPC)
MA MD
DOCDB simple family (publication)
WO 2018045130 A1 20180308; CA 3035202 A1 20180308; CN 109789196 A 20190521; CN 109789196 B 20240319; CN 118141914 A 20240607; EP 3506931 A1 20190710; EP 3506931 B1 20240731; EP 4442323 A2 20241009; JP 2019531273 A 20191031; JP 2022169718 A 20221109; JP 7542582 B2 20240830; KR 102462039 B1 20221102; KR 20190042702 A 20190424; KR 20220151021 A 20221111; KR 20240065318 A 20240514; MA 46098 A 20190710; MX 2019002344 A 20190906; MX 2023004306 A 20230504; PT 3506931 T 20240821; US 11771743 B2 20231003; US 2019183973 A1 20190620; US 2024082353 A1 20240314
DOCDB simple family (application)
US 2017049538 W 20170831; CA 3035202 A 20170831; CN 201780053319 A 20170831; CN 202410243164 A 20170831; EP 17771619 A 20170831; EP 24182364 A 20170831; JP 2019511889 A 20170831; JP 2022134609 A 20220826; KR 20197009282 A 20170831; KR 20227037662 A 20170831; KR 20247014525 A 20170831; MA 46098 A 20170831; MX 2019002344 A 20170831; MX 2023004306 A 20190227; PT 17771619 T 20170831; US 201716329184 A 20170831; US 202318452155 A 20230818